Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 4, 2014, Pages 454-460

  Napiórkowska, Agnieszka ^a   Rusch Gerdes S ^b   Hillemann, D ^b   Richter, E ^b   Augustynowicz Kopec E ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b Forschungszentrim Borstel   (Germany)

Author keywords

pncA gene; Pyrazinamide; Resistance; Transmission

Indexed keywords

PYRAZINAMIDE; AMIDASE; BACTERIAL DNA; PNCA PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA FINGERPRINTING; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE INSERTION SEQUENCE; GENE LOCUS; GENETIC PROCEDURES; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; MYCOBACTERIAL INTERSPERSED REPETITIVE UNIT VARIABLE NUMBER OF TANDEM REPEAT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; POINT MUTATION; POLAND; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPOLIGOTYPING; VARIABLE NUMBER OF TANDEM REPEAT; CLINICAL TRIAL; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRANSMISSION; TUBERCULOSIS, PULMONARY;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLAND; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYRAZINAMIDE; TUBERCULOSIS, PULMONARY;

EID: 84897136493     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0457     Document Type: Article

References (29)

1. Hou L, Osei Hyiaman D, Zhang Z, Wang B, Yang A, Kano K. Molecular characterization of pnc A gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol Infect 2000; 124: 227-232. (Pubitemid 30224130)
2. Barco P, Cardoso R F, Hirata R D C, et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 2006; 58: 930-935.
3. Boshoff H I, Mizrahi V. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J Bacteriol 2000; 182: 5479-5485.
4. Boshoff H I, Mizrahi V, Barry C E. Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase. J Bacteriol 2002; 184: 2167-2172. (Pubitemid 34259666)
5. Huang T, Lee S S, Tu H. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob Agents Chemother 2003; 47: 3672-3673. (Pubitemid 37345747)
6. Portugal I, Barreiro L, Moniz-Pereira J. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal. Antimicrob Agents Chemother 2004; 48: 2736-2768.
7. Muthuraj M, Sridharan J, Nisha A, et al. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of Mycobacterium tuberculosis from South India. Int J Mol Sci 2010; 11: 2670-2680.
8. Shi W, Zhang X, Jiang X, et al. Pyrazinamide inhibits transtranslation in Mycobacterium tuberculosis: a potential mechanism for shortening the duration of tuberculosis chemotherapy. Science 2011; 333: 1630-1632.
9. Somoskovi A, Dormandy J, Parsons L M, et al. Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: identification of a species-specific pncA mutation in 'Mycobacterium canettii' and the reliable and rapid predictor of pyrazinamide resistance. J Clin Microbiol 2007; 45: 595-599. (Pubitemid 46277031)
10. van Embden J D A, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA finger-printing: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409. (Pubitemid 23028649)
11. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914. (Pubitemid 27146535)
12. Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang Y W. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J Clin Microbiol 2010; 48: 3544-3450.
13. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and user-strategy of MIRU-VNTR plus, a multifunctional database for on-line analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008; 46: 2692-2699.
14. Barniol J, Niemann S, Louis V R, et al. Transmission dynamics of pulmonary tuberculosis between autochthonous and immigrant sub-populations. BMC Infect Dis 2009; 4: 197.
15. Yeager R, Monroe W G C, Dessau F I. Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis. Am Rev Tuberc 1952; 65: 523-546.
16. Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z. Resistance to pyrazinamide among Mycobacterium tuberculosis strains isolated from patients from the Mazovian Voivodeship in 2008-2010 years. Postȩpy Nauk Medycznych 2011; XXIV: 819-823. [Polish]
17. Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z. Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland. Pneumonol Alergol Pol 2010; 78: 256-262.
18. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis 1998; 78: 117-122.
19. Scorpio A, Lindholm-Levy P, Heifets L, et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 540-543. (Pubitemid 27098400)
20. Morlock G P, Crawford J T, Butler W R, et al. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 2291-2295. (Pubitemid 30650870)
21. Stoffels K, Mathys V, Fauville-Dufaux M, Wintjens R, Bifani P. Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2012; 56: 5186-5193.
22. Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. PLOS ONE 2011; 6: e15785.
23. Zhang H, Deng J Y, Bi L J, et al. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. FEBS J 2008; 275: 753-762.
24. Tracevska T, Jansone I, Baumanis V, Nodieva A, Marga O, Skenders G. Spectrum of pncA mutations in multidrug-resistant Mycobacterium tuberculosis isolates obtained in Latvia. Antimicrob Agents Chemother 2004; 48: 3209-3210. (Pubitemid 38989208)
25. Fernandes P, Ferreira B S, Cabral J M S. Solvent tolerance in bacteria: role of efflux and cross-resistance with antibiotics. Int J Antimicrob Agents 2003; 2: 211-216. (Pubitemid 37103202)
26. Cheng S, Thilbert L, Sanchez T, et al. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 2000; 44: 528-532. (Pubitemid 30117936)
27. Alexander D C, Ma J H, Guthrie J L, Blair J, Chedore P, Jamieson F B. Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA. J Clin Microbiol 2012; 50: 3726-3728.
28. Salfinger M, Heifets L B. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pH by the radiometric method. Antimicrob Agents Chemother 1998; 32: 1002-1004.
29. Park S K, Lee J, Chang C L, et al. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC Infect Dis 2001; 1: 4.